$19.31
-0.36-1.83%
At close: -
$19.31
0.000.00%
After Hours: 1:00 PM EDT
Comments
Loading...
Viridian Therapeutics (VRDN) Forecast
NewsEarningsViridian Therapeutics (VRDN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestViridian Therapeutics (NASDAQ:VRDN) Stock Quotes, Forecast and News Summary
Viridian Therapeutics Stock (NASDAQ: VRDN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Viridian Therapeutics (VRDN) stock?
You can purchase shares of Viridian Therapeutics (NASDAQ:VRDN) through any online brokerage.
Who are Viridian Therapeutics (VRDN) competitors?
Other companies in Viridian Therapeutics’s space includes: Arcutis Biotherapeutics (NASDAQ:ARQT), Day One Biopharmaceutical (NASDAQ:DAWN), Xencor (NASDAQ:XNCR), Mesoblast (NASDAQ:MESO) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
What is the forecast, or price target, for Viridian Therapeutics (VRDN) stock?
Viridian Therapeutics has a consensus price target of $38.73.
What is the current price for Viridian Therapeutics (VRDN)?
The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $19.31 last updated December 24, 2024 at 1:00 PM EST.
Does Viridian Therapeutics (VRDN) pay a dividend?
There are no upcoming dividends for Viridian Therapeutics.
When is Viridian Therapeutics (NASDAQ:VRDN) reporting earnings?
Viridian Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
Is Viridian Therapeutics (VRDN) going to split?
There is no upcoming split for Viridian Therapeutics.
What sector and industry does Viridian Therapeutics (VRDN) operate in?
Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.